Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

118.13
Delayed Data
As of Sep 30
 +0.86 / +0.73%
Today’s Change
91.76
Today|||52-Week Range
126.07
+15.00%
Year-to-Date
Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson
11:43am / MotleyFool.com - Paid Partner Content
Intra-Cellular Reports Poor Phase III Schizophrenia Data
Sep 29 / Zacks.com - Paid Partner Content
Analyst Says Cooper is Poised to Gain Market Share
Sep 30 / TheStreet.com - Paid Partner Content
How Oncology Could Move the Needle for Johnson & Johnson's Stock
Sep 29 / MotleyFool.com - Paid Partner Content
Hey Gilead, It's Time to Start Looking Over Your Shoulder in Hepatitis C
Sep 30 / MotleyFool.com - Paid Partner Content
Better Buy: Johnson & Johnson vs. AbbVie
Sep 28 / MotleyFool.com - Paid Partner Content
Valuation Is a Measurement of Soundness and Not the Primary Total Return Producer: Pa...
Sep 29 / GuruFocus News - Paid Partner Content
Ratings on the Largest Stocks - Buy, Neutral or Avoid
Sep 28 / GuruFocus News - Paid Partner Content
Troubles for Deutsche Bank, Wells Fargo Drag Down Wall Street
Sep 29 / TheStreet.com - Paid Partner Content
3 Stocks With Better Dividends Than Procter & Gamble
Sep 28 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close117.27
Today’s open117.78
Day’s range117.39 - 118.62
Volume7,941,065
Average volume (3 months)6,581,498
Market cap$323.2B
Dividend yield2.71%
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-3.86%
Earnings growth (this year)+7.89%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-5.56%
P/E ratio22.0
Price/Sales4.12
Price/Book4.57

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.55+1.65%
NVSNovartis-0.29-0.37%
MRKMerck+0.50+0.81%
GSKGlaxoSmithKline+0.23+0.54%
Data as of 4:02pm ET, 09/30/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$1.65
Annual revenue (last year)$70.2B
Annual profit (last year)$15.4B
Net profit margin21.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Vice President
Dominic J. Caruso
Corporate headquarters
New Brunswick, New Jersey

Forecasts

Search for Jobs